The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Camrelizumab (Camre) plus taxane-based chemotherapy (CT): Clinical outcomes and dynamic monitoring of CEA as a predictive biomarker of response in patients with recurrent or advanced esophageal squamous cell carcinoma (ESCC).
 
Cheng Kong
No Relationships to Disclose
 
Jianhua Xu
No Relationships to Disclose
 
Ming Jiang
No Relationships to Disclose
 
Xiangzhi Zhu
No Relationships to Disclose
 
Jinjun Ye
No Relationships to Disclose
 
Shaorong Yu
No Relationships to Disclose
 
Jun Zhu
No Relationships to Disclose